\u00a9 iStock\/Nicolas<\/figcaption><\/figure>\nProfessor Dame Ottoline Leyser, the Chief Executive of UKRI, said: \u201cThis new funding is a testament to the flourishing innovation sector in the UK. UKRI continues to support a vibrant community of start-up and spin-out companies, demonstrating that from the seed of an idea, with careful watering, the boldest and innovative breakthroughs can grow.<\/p>\n
\u201cThanks to seed fund investment, these companies are mining the rich vein of research carried out in laboratories across the UK to deliver solutions to real-world problems and address some of the biggest challenges in medicine, sustainability and technology.\u201d<\/p>\n
Professor Mark Thomson, Executive Chair of STFC, said: \u201cThis new funding allows a new cohort of scientific innovators and entrepreneurs to design the products and services that transform our everyday lives.<\/p>\n
\u201cFrom life-changing medical breakthroughs to cutting-edge technological advances, these ambitious spin-out companies are responsible for tackling some of the biggest problems and challenges in society. The success stories from this high-risk, high-reward fund prove that the entrepreneurial spirit is alive and well in the UK.\u201d<\/p>\n
Midven, an industry-leading venture capital specialist, independently operate the seed fund. Their director of the fund manager, Andrew Muir, said: \u201cMore than 75%of the \u2018deep science\u2019 companies\u00a0we have backed would almost certainly not have\u00a0got off the ground without our initial funding, advice and assistance.<\/p>\n
\u201cThose companies are now worth around \u00a31bn and have created hundreds of highly skilled jobs. The UK\u2019s entrepreneurial spirit is alive and well, and so this additional funding is great news for the next generation of founders.\u201d<\/p>\n
Success stories<\/h3>\n The Electrospinning Company (TECL), a branch of STFC, is an industry pioneer in the manufacturing of nanofibers nanofibrous biomaterials utilised for tissues in regenerative devices and has been supported by UKI2S since 2010. Now comprised of 14 employees and many clients around the world, the company supplies the first FDA-approved medical device containing an electrospun material, recently conducting a \u00a34.5m fundraising round.<\/p>\n
Helix Technologies is a UK antenna developer that has successfully got its precision Global Navigation Satellite System (GNSS) into production after raising \u00a3500,000, allowing the company to reinforce their engineering team and finance the upscaling of production.<\/p>\n
UK company Tropic Biosciences\u00a0\u00a0 – who work to provide nutritionally dense food in a sustainable approach to people in the tropics \u2013 received a \u00a3241,000 investment from the UKI2s fund for synthetic biology, allowing the accompany the advance its development, raising $28.5m and now involving 61 full-time employees.<\/p>\n","protected":false},"excerpt":{"rendered":"
UKRI will be financing \u00a310 million to the UK Innovation and Science Seed Fund(UKI2S), ensuring world-leading scientific research.<\/p>\n","protected":false},"author":15,"featured_media":12748,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[766,24429],"tags":[3475,24605,763,821],"acf":[],"yoast_head":"\n
UKRI pledge substantial funding to UK Innovation and Science Seed Fund<\/title>\n \n \n \n \n \n \n \n \n \n \n \n \n \n\t \n\t \n\t \n \n \n \n \n \n\t \n\t \n\t \n